BRAF and melanoma: In order to determine whether the MEK1T55delinsRT mutation conferred resistance to BRAF inhibition in vivo also, A375 melanoma cells, after they had been retrovirally transduced with cDNAs encoding GFP, MEK1WT or MEK1T55delinsRT, were injected subcutaneously into immune-deficient mice.